A consortium agreement was inked on 16 October 2018 between the Agency for Science, Technology and Research (A*STAR), National University of Singapore (NUS), Nanyang Technological University, Singapore (NTU Singapore), Singapore Institute of Technology (SIT) and three major pharmaceutical MNCs, i.e. GlaxoSmithKline (GSK), MSD International GmbH (Singapore branch) and Pfizer Asia Pacific. They are also the founding members of PIPS. Syngenta Crop Protection AG (Syngenta) joined the consortium in December 2019 as the 4th core member. A world-leading agrochemicals company, Syngenta uses manufacturing technologies almost identical to pharmaceutical small molecule API processing and is very keen to share their experience and learn from PIPS. In addition, PIPS comprises academic partners in NUS, NTU Singapore, SIT, Cambridge Centre for Advanced Research and Education in Singapore (CARES) and Singapore-MIT Alliance for Research and Technology (SMART).
The Extended Team is a diverse group consisting pharmaceutical supply chain, technology, consultancy, training and engineering companies, including SMEs and LLEs invited by the core members to participate in specific projects. They include the following companies.
Note: Companies are listed in alphabetical order.